Fast Growing Australian MedTech Startup RxMx Partners with InterSystems to Enhance the Safe Use of New Medicines
Summary
Using the InterSystems database platform, RxMx has built and deployed an automated patient monitoring system for complex medicines that require ongoing laboratory testing for potential adverse effects.The company will migrate to InterSystems IRIS for Health™ , the first and only data platform engineered specifically for healthcare, to adapt to an extremely rapidly changing environment, according to RxMx Co-founder, Associate Professor Sean Riminton.“We are working towards continuous deployment and we know that InterSystems IRIS for Health can facilitate that with support for container technology,” said Ben Rhodes, Software Development Manager for RxMx, adding that the company’s interoperability requirements are also expanding.“With clinically proven technology solutions that improve patient safety and which are deployed around the world, RxMx has achieved an enormous amount in a very short time,” said Luciano Brustia, Country Manager, Australia and Greater China for InterSystems.Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 80 countries.